[Skip to content]

Enter search here...
Worcestershire Key Documents
.
.

Oncology and Cancer Services Key Documents

Please note that the clinical key documents are not designed to be printed, but to be viewed on-line.  This is to ensure that the correct and most up to date version is being used.  If, in exceptional circumstances, you need to print a copy, please note that the information will only be valid for 24 hours and should be read in conjunction with the Key Document Supporting Information and/or Key Document intranet page, which will provide additional information including approval and review dates

Using the Key Document page

West Midlands Cancer Alliance Policy and Guidelines for the Investigation, Diagnosis and Management of Patients with Malignancy of an Unknown Origin (MUO) and Cancer of an Unknown Primary (CUP) 

Review date - 16th December 2022

This is the most current document and should be used until a revised version is in place  

Worcester Acute Hospitals NHS local pathway for referral of all patients with a metastatic cancer of unknown origin/cancer of unknown primary

Review date - 9th November 2020

This is the most current document and should be used until a revised version is in place

Operational escalation policy for monitoring cancer 14/31/62 day targets 

Review date - 21st November 2020

This is the most current document and should be used until a revised version is in place

Key worker policy

Review date - 26th February 2021 

This is the most current document and should be used until a revised version is in place

Policy for the Management of Cancer patients for whom Drugs their Clinicians have recommended are not available on the NHS

Review date - 22nd November 2020

This is the most current document and should be used until a revised version is in place

Scalp cooling Guidelines for Adult Oncology Patients West Midlands Expert Advisory Group for Systemic Anti Cancer Therapy (SACT)

Review date - 1st March 2021

This is the most current document and should be used until a revised version is in place

Operational guideline for cancer services

Review date - 1st May 2021

This is the most current document and should be used until a revised version is in place

Nurse led 2 week wait clinic for suspected colorectal cancer patients  

Review date - 5th November 2020 

This is the most current document and should be used until a revised version is in place  

Safe prescribing, handling and administration of chemotherapy drugs

Review date - 15th May 2021

This is the most current document and should be used until a revised version is in place

Guideline for the management of Immune related Adverse Reactions following Immunotherapy Treatment

Review date - 9th November 2020

This is the most current document and should be used until a revised version is in place

Guideline for the management of extravasation of a cytotoxic agent or a monoclonal antibody used in the treatment of malignant disease

Review date - 21st November 2020

This is the most current document and should be used until a revised version is in place

Guidelines for the Management of Extravasation of a systemic Anti-Cancer therapy including Cytotoxic agents - West Midlands Expert Advisory Group for Systemic Anti-Cancer therapy (SACT) 

Review date - 16th December 2022

This is the most current document and should be used until a revised version is in place 

Cancer Quality Surveillance Policy 

Review date - 28th January 2019

 This is the most current document and should be used until a revised version is in place

Cancer Quality Surveillance Policy Supporting Information

Quality Surveillance Team (Formerly National Cancer Peer Review Programme)

Cancer Patients Who Wish to Pay Privately for Chemotherapy Drugs Not Covered by the NHS

Review Date – 10th August 2020

This is the most current document and should be used until a revised version is in place

West Midlands Cancer Alliance Guideline for the use of Antiemetics in adults receiving Anticancer Drug Therapy 

Review Date – 12th December 2022

This is the most current document and should be used until a revised version is in place

The following documents are Birmingham Children's Hospital policies and permission has been granted for these to be used- 

Cover letter for Paediatric Oncology Policies

Guideline for the Management of Tumour Lysis Syndrome

Guideline for the Administration of Chemotherapy for Malignant Disease 

Guideline for the immunisation of Children following treatment with Standard-dose Chemotherapy 

Guideline for the immunisation of Children following treatment with high-dose Chemotherapy 

Procedure for the managment of body waste and clinical samples from patients receiving Cytotoxic drugs 

CCLG and Birmingham Women's and Children's Hospital Guideline on the Management of Chemotherapy Induced Nausea and Vomiting

Guideline for the prevention, recognition and management of fever in Children and Young People with Cancer 

Procedure for the Management of spillage of cytotoxic drugs 

Policy for the use of personal protective Equipment when handling chemotherapy, spillage of chemotherapy, body waste and/or clinical samples from patients receiving chemotherapy 

Policy for the Care and Management of central venous catheters 

Policy for the care and management of ports 

Policy on the Handling of chemotherapy by staff who are pregnant or breastfeeding 

Guidelines for the Prevention and Management of Chemotherapy and Radiotherapy induced Diarrhoea 

Page last updated: 29 September 2020